AI-generated summary
In this animal study, the authors tested photobiomodulation at several doses on excisional wounds in diabetic rats with induced neuropathy. They report that doses of 4, 6 and 8 J/cm2 at 655 nm and 808 nm were associated with better wound healing and optimized levels of matrix metalloproteinases-1 and 8. The authors call for human randomized trials to validate these findings.
- Participants
- 126
- Who or what was studied
- Diabetic Albino Wistar rats with sciatic nerve injury-induced neuropathy and excisional wounds
- Wavelengths
- 655, 808 nm
- Limits stated in the abstract
- The study is an in vivo animal study, and the authors state that human clinical trials are needed to confirm safety and efficacy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm, 808 nm
- Total energy
- 15 J, 8 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Dose, Dose-response relationship, Neuropathy, Wound healing, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.